ROYAL BANK OF CANADA - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 27 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$043
+377.8%
0.00%
Q4 2017$090.0%0.00%
Q3 2017$09
+200.0%
0.00%
Q1 2017$030.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
NEA Management Company, LLC 1,889,652$26,531,0001.20%
WALL STREET ASSOCIATES 250,000$3,510,0000.33%
QVT Financial LP 368,330$5,001,0000.28%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 485,000$6,809,0000.22%
Perceptive Advisors 100,000$1,404,0000.11%
Visium Asset Management, LP 461,336$6,477,0000.10%
Opaleye Management Inc. 12,172$171,0000.08%
Candriam S.C.A. 125,000$1,755,0000.04%
Spark Investment Management LLC 13,300$186,0000.03%
Nicholas Investment Partners, LP 30,000$421,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders